Table 1.
Assessment measures and timeline.
| Instrument | Purpose/Domain | BSL | Weekly | End of TX | 1-Month Follow-Up |
|---|---|---|---|---|---|
| Informed Consent | Obtain informed consent | X | |||
| Demographics Form | Characterize sample demographics | X | |||
| MINI International Neuropsychiatric Interview | Assess DSM-5 psychiatric disorders | X | |||
| Adverse Events: AEs | Monitor AEs and safety | X | X | X | |
| Life Events Checklist | Assess lifetime trauma exposure | X | |||
| Clinician Administered PTSD Scale: CAPS-5 | PTSD symptom severity (clinician-rated) | X | X | X | |
| PTSD Checklist: PCL-5 | PTSD symptom severity (self-report) | X | X | X | X |
| Beck Depression Inventory-II: BDI-II | Measure depressive symptoms | X | X | X | X |
| Client Satisfaction Questionnaire-8: CSQ | Assess satisfaction with treatment | X | |||
| Helping Alliance Questionnaire: HAQ-II | Measure therapeutic alliance | X | |||
| System Usability Survey: SUS | Assess usability and comfort | X | X | ||
| In Vivo Exposures: IVEs | Assess biological and self-report indices of engagement (HR, GSR, SUDS), feasibility, and acceptability | X |
Note. BSL = baseline, TX = treatment, HR = heart rate, GSR = galvanic skin response, SUDS = Subjective Units of Distress Scale.